South Korea's MFDS Framework: How Health Functional Foods Apply to EBC-46 Supplements

South Korea operates one of Asia's most structured frameworks for botanical and dietary supplement oversight. For consumers and brands working with EBC-46 — the diterpene ester family found in blushwood berry (Fontainea picrosperma) — understanding how the Korean regulatory system classifies a product determines whether it can be sold legally and how it must be labelled. This article walks through the key categories, the role of the Ministry of Food and Drug Safety (MFDS), and how the system compares with the United States' DSHEA approach that governs most EBC-46 supplements sold internationally today.

The MFDS and the two-track regulatory system

The MFDS regulates foods, drugs, cosmetics, and medical devices in South Korea. Within the food category sit three relevant sub-categories: general foods, foods for special dietary uses, and Health Functional Foods (HFF). The HFF designation, established by the Health Functional Foods Act of 2002, applies to products that contain functional ingredients with documented physiological effects. Functional ingredients fall into two streams — the "Notified" list (ingredients with established standards published by MFDS) and the "Individual Approval" stream (case-by-case approval for novel ingredients). A blushwood berry extract supplement, being a relatively novel botanical from a Korean regulatory perspective, would currently sit in the Individual Approval stream rather than the Notified list.

Where EBC-46 supplements fit

Most EBC-46 supplements on the market are sold internationally as dietary supplements under the United States' Dietary Supplement Health and Education Act (DSHEA), which is the established legal framework for botanical supplements containing whole-plant extracts. Korea's system is different in approach. To sell a blushwood berry extract product in Korea as an HFF — and make any structure-function claims — a manufacturer would need to submit safety, efficacy, and standardisation data to MFDS for Individual Approval. Without HFF status, the product can still potentially be imported and sold as a general food supplement, but cannot carry functional health claims on the label.

How the Korean framework compares with DSHEA

Both DSHEA and the Korean HFF framework share a key principle: dietary supplements are not drugs, and supplement labels cannot make disease treatment claims. The required FDA disclaimer — "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease" — is paralleled by similar non-therapeutic-claim language in the Korean system. Where the systems diverge is in claim authorisation: DSHEA permits general structure-function claims so long as the manufacturer holds substantiation, whereas Korea's HFF system permits only claims that have been pre-approved through the Notified or Individual Approval pathway. For more on how DSHEA frames botanical supplements, see the US FDA dietary supplements guidance page.

What this means for buyers in Korea

A consumer in South Korea looking for an EBC-46 supplement today is most likely purchasing through international e-commerce or specialty importers. The product they receive is regulated under the laws of its country of origin — typically the United States — rather than under MFDS rules. The practical implications are: the label will follow US Supplement Facts conventions; the manufacturing standard will be US current Good Manufacturing Practice (cGMP) for dietary supplements; and any third-party lab certificates will reflect international, not Korean, accreditation bodies. Reference-quality suppliers like Blushwood Health publish independent batch testing through Eurofins Scientific, which holds ISO/IEC 17025:2017 accreditation recognised globally.

Quality standards a Korean buyer should expect

Whether a supplement is sold under Korean HFF rules or imported from a DSHEA-regulated brand, the quality fundamentals are the same: independently tested for heavy metals (arsenic, lead, cadmium, mercury) and microbial contaminants (E. coli, Salmonella, yeast and mould); manufactured in a GMP-certified facility; declared with a transparent extraction ratio; and accompanied by batch-specific certificates of analysis. The Korean Korea Food and Drug Administration consumer information portal publishes guidance on what to look for when buying imported supplements. These criteria match the international quality benchmarks discussed across this site's broader coverage.

The regulatory direction of travel

Several Asian regulators — Singapore's Health Sciences Authority, Japan's MHLW, and Korea's MFDS — have over the past decade harmonised some aspects of botanical supplement oversight with international norms while preserving distinct local approval pathways. For a novel ingredient like blushwood berry extract, the most likely commercial pathway in Korea over the next several years remains international supply to Korean buyers via e-commerce, with HFF-status products following only if a manufacturer commits to the Individual Approval process. This is the established legal route — not a regulatory grey zone — and reflects the same approach that applies to many other novel botanical ingredients entering the Korean market.

Bottom line

The MFDS framework gives South Korean consumers a structured system that distinguishes general foods from health-claim-bearing functional foods. EBC-46 supplements currently reach Korean buyers primarily through international DSHEA-regulated brands. The quality questions a Korean buyer should ask are the same ones a US or European buyer should ask: who tested it, what did the certificate of analysis show, and does the manufacturer declare the extraction ratio and serving size clearly. These are the standards that brands like Blushwood Health are built around, and they translate across regulatory systems.

Related articles

• New Zealand's Medsafe and natural health product regulation
• Health Canada NHPD and natural health products
• Blushwood berry extract: a natural EBC-46 supplement

Citations

1. Ministry of Food and Drug Safety, Republic of Korea (English portal), 2026.

2. US FDA — Dietary Supplements, 2026.

3. Blushwood Health — EBC-46 Independent Lab Tests, 2026.

4. Korea Food and Drug Administration — Consumer Information, 2026.